Embabel has reached its 1.0 release, providing a framework for AI agents on Java It allows Java and Kotlin developers to ...

When a buyer asks a bottom-of-funnel question and the retrieval pool is thin or non-existent, the model comes unstuck. AI is ...

The short-term release enters its first release candidate stage on August 6, with general availability set for September 15, as Oracle and the OpenJDK community lock in a nine-JEP feature set anchored ...

Overview:  Master the most frequently asked Golang interview questions covering language fundamentals, concurrency, ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...

Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...

Share on Pinterest Federal regulators have agreed to review a Swiss pharmaceutical company’s applications for two cheaper generic versions of Zepbound and Mounjaro. MK Photo/Alamy Stock Photo Federal ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

Most interview-prep content is generic: "here's how you'd design a RAG system" as a thought experiment. This repo is different in two ways. First, the system-design/ questions follow ...

The Portuguese soccer player called on another reporter before the question about his rival was finished Pat Elmont - FIFA/FIFA via Getty; Karl Bridgeman - FIFA/FIFA via Getty Cristiano Ronaldo ...

FDA cleared generic rifapentine for active pulmonary TB (≥12 years) with susceptible isolates, requiring combination therapy with other active antitubercular agents. Authorization also covers LTBI (≥2 ...